176
Participants
Start Date
June 25, 2024
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Immunotherapy,Toripalimab Injection
Patients in the experimental group would be implemented with adjuvant Immunotherapy and chemotherapy after endoscopic surgery. Four to six cycles chemotherapy and 10 cycles immunotherapy,or until unacceptable side effects.
Chemotherapy,Gemcitabine based regimen
Patients in the experimental group would be implemented with adjuvant Immunotherapy and chemotherapy after endoscopic surgery. Four to six cycles chemotherapy and 10 cycles immunotherapy,or until unacceptable side effects.
RECRUITING
Eye& ENT Hospital, Fudan University, Shanghai
NOT_YET_RECRUITING
Fujian Medical University Union Hospital, Fuzhou
RECRUITING
The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning
RECRUITING
Changhai Hospital, Shanghai
NOT_YET_RECRUITING
Shanghai Sixth People's Hospital, Shanghai
NOT_YET_RECRUITING
Shanghai Zhongshan Hospital, Shanghai
NOT_YET_RECRUITING
Shenzhen Second People's Hospital, Shenzhen
Shanghai Zhongshan Hospital
OTHER
Shanghai 6th People's Hospital
OTHER
Changhai Hospital
OTHER
Fujian Medical University Union Hospital
OTHER
People's Hospital of Guangxi Zhuang Autonomous Region
OTHER
Shenzhen Second People's Hospital
OTHER
Eye & ENT Hospital of Fudan University
OTHER